Product

GEH121224

Aliases

GEH121224 (18F) Injection

1 clinical trial

1 indication

Indication

Clinical trial

A Phase 1 Study to Assess the Safety, Radiation Dosimetry and Biodistribution, and Basic Pharmacokinetics of [18F]GEH121224 and Determine the Optimal Timing of Imaging in Patients With Locally Advanced or Metastatic Breast Cancer.

Status: Not yet recruiting, Estimated PCD: 2025-12-01